Novartis Int AG declared aspiration to become most expensive pharmaceutical company in the world

Moscow, 1 Feb — the PRIME. General director Novartis Int AG declared that seeks to make the Swiss farmproizvoditel most expensive pharmaceutical company in the world. Acting at a briefing by financial results of 2022, general director Vas Narasimkhan noted that company has to come out on top "not only at market cost, but also on trust level to itself". Besides, he added that the pricing policy on the drugs, pursued in Europe, in his opinion, reduces investment appeal of this region in the opinion of developers of drugs. Nevertheless he confirmed that him company intends...